Superficial Thrombophlebitis

Superficial Thrombophlebitis is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Thrombophlebitis superficial
Classified under: Cardiovascular Diseases
Immune System Diseases
Wounds and Injuries
Indicated drugs: beta-Escin
Naftazone
Polysulfated glycosaminoglycan

Resolves to

Vocabularies

SNOMED CT155453005MedDRA10042545UMLSC0235511

What you can answer from here — as of November 06, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

3Clinical trialsPhase, status and sponsor resolved per trial

6Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Superficial Thrombophlebitis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.